EC11303
Escherichia coli
Strain B, lyophilized cells
Synonym(s):
E. coli
Sign Into View Organizational & Contract Pricing
All Photos(3)
About This Item
Recommended Products
Quality Level
sterility
non-sterile (not processed or packaged aseptically)
form
lyophilized cells
suitability
not intended for starter culture
storage temp.
−20°C
Looking for similar products? Visit Product Comparison Guide
General description
Escherichia coli is a non-pathogenic, facultative anaerobic flora present in the intestine of human. It belongs to the genus, Escherichia, which consists of motile gram-negative bacilli.
Application
Escherichia coli has been used:
- in the isolation of DNA from lyophilized cell
- in the preparation of crude cell lysate for developing scalable purification method for recombinant protein A
- as test proteome for comparative electrophoresis
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Diarrheagenic Escherichia coli
Clinical Microbiology Reviews, 11(1), 142-201 (1998)
Horizontal comparative fluorescence two-dimensional gel electrophoresis for improved spot coordinate detection
Electrophoresis, 35(8), 1118-1121 (2014)
Accelerated recombinant protein purification process development: Automated, robotics-based integration of chromatographic purification and analysis
Journal of Chromatography A, 798(1), 73-82 (1998)
Severe atopic dermatitis is associated with a high burden of environmental Staphylococcus aureus
Clinical and Experimental Allergy, 38(5), 789-793 (2008)
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 38(5), 789-793 (2008-03-18)
About 90% of patients with atopic dermatitis (AD) are colonized with Staphylococcus aureus. S. aureus worsens AD by secreting superantigens and structural molecules within the cell wall that induce skin inflammation. Therefore, S. aureus in the home may contribute to
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service